Targetable molecular alterations in congenital glioblastoma
Ahmed Gilani(Children's Hospital Colorado), Adam L. Green(Morgan Adams Foundation), Kurtis D. Davies(University of Colorado Anschutz Medical Campus), John DeSisto(Morgan Adams Foundation), Andrew M. Donson(Children's Hospital Colorado), Lindsey M. Hoffman(St Nicholas Hospital), Jessica Lake(National Institutes of Health), Susan L. Whiteway(Uniformed Services University of the Health Sciences), Bette K. Kleinschmidt‐DeMasters(University of Colorado Denver), Nicholas K. Foreman(Morgan Adams Foundation)
Cited by 39
Related Papers
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
|Nature Genetics|2014|659
Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries
|Journal of Clinical Oncology|2018|433
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
|Journal of Clinical Oncology|2017|345